Primecap Management CO Biomarin Pharmaceutical Inc Transaction History

Primecap Management CO

  • $122 Billion
  • Q2 2025

A detailed history of Primecap Management CO transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Primecap Management CO holds 15,772,173 shares of BMRN stock, worth $897 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
15,772,173
Previous 17,773,281 11.26%
Holding current value
$897 Million
Previous $1.26 Billion 30.99%
% of portfolio
0.71%
Previous 1.06%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$54.08 - $68.32 $108 Million - $137 Million
-2,001,108 Reduced 11.26%
15,772,173 $867 Million
Q1 2025

May 09, 2025
SELL
$61.25 - $72.83 $25.5 Million - $30.3 Million
-415,890 Reduced 2.29%
17,773,281 $1.26 Billion
Q4 2024

Feb 10, 2025
SELL
$61.93 - $70.49 $42 Million - $47.8 Million
-678,264 Reduced 3.59%
18,189,171 $1.2 Billion
Q3 2024

Nov 08, 2024
BUY
$69.02 - $93.84 $5.34 Million - $7.26 Million
77,350 Added 0.41%
18,867,435 $1.33 Billion
Q2 2024

Aug 09, 2024
BUY
$74.43 - $92.22 $5.67 Million - $7.03 Million
76,190 Added 0.41%
18,790,085 $1.55 Billion
Q1 2024

May 13, 2024
BUY
$83.81 - $99.0 $25.1 Million - $29.7 Million
299,521 Added 1.63%
18,713,895 $1.63 Billion
Q4 2023

Feb 09, 2024
BUY
$76.22 - $98.51 $597,183 - $771,825
7,835 Added 0.04%
18,414,374 $1.78 Billion
Q3 2023

Nov 13, 2023
BUY
$85.07 - $94.48 $1.95 Million - $2.17 Million
22,920 Added 0.12%
18,406,539 $1.63 Billion
Q2 2023

Aug 11, 2023
BUY
$86.68 - $100.3 $12.2 Million - $14.1 Million
140,190 Added 0.77%
18,383,619 $1.59 Billion
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $58.1 Million - $77.7 Million
662,570 Added 3.77%
18,243,429 $1.77 Billion
Q4 2022

Feb 13, 2023
SELL
$80.93 - $108.63 $3.61 Million - $4.85 Million
-44,646 Reduced 0.25%
17,580,859 $1.82 Billion
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $4.35 Million - $5.14 Million
-52,980 Reduced 0.3%
17,625,505 $1.49 Billion
Q2 2022

Aug 11, 2022
SELL
$71.48 - $86.85 $7.22 Million - $8.77 Million
-100,985 Reduced 0.57%
17,678,485 $1.47 Billion
Q1 2022

May 11, 2022
SELL
$74.28 - $92.69 $1.88 Million - $2.35 Million
-25,310 Reduced 0.14%
17,779,470 $1.37 Billion
Q4 2021

Feb 11, 2022
SELL
$71.72 - $91.47 $9.51 Million - $12.1 Million
-132,550 Reduced 0.74%
17,804,780 $1.57 Billion
Q3 2021

Nov 12, 2021
SELL
$74.77 - $85.47 $1.18 Million - $1.34 Million
-15,736 Reduced 0.09%
17,937,330 $1.39 Billion
Q2 2021

Aug 10, 2021
SELL
$75.51 - $84.79 $15.5 Million - $17.4 Million
-204,728 Reduced 1.13%
17,953,066 $1.5 Billion
Q1 2021

May 14, 2021
BUY
$74.73 - $90.69 $734,820 - $891,754
9,833 Added 0.05%
18,157,794 $1.37 Billion
Q4 2020

Feb 08, 2021
SELL
$72.61 - $90.2 $3.16 Million - $3.93 Million
-43,580 Reduced 0.24%
18,147,961 $1.59 Billion
Q3 2020

Nov 13, 2020
BUY
$71.87 - $131.03 $22.1 Million - $40.3 Million
307,570 Added 1.72%
18,191,541 $1.38 Billion
Q2 2020

Aug 13, 2020
BUY
$79.55 - $124.22 $5.9 Million - $9.22 Million
74,204 Added 0.42%
17,883,971 $2.21 Billion
Q1 2020

May 14, 2020
BUY
$71.37 - $96.85 $106 Million - $143 Million
1,480,447 Added 9.07%
17,809,767 $1.5 Billion
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $75 Million - $101 Million
1,167,246 Added 7.7%
16,329,320 $1.38 Billion
Q3 2019

Nov 13, 2019
BUY
$67.4 - $85.11 $59.2 Million - $74.8 Million
878,321 Added 6.15%
15,162,074 $1.02 Billion
Q2 2019

Aug 14, 2019
BUY
$80.35 - $93.9 $7.46 Million - $8.72 Million
92,880 Added 0.65%
14,283,753 $1.22 Billion
Q1 2019

May 14, 2019
BUY
$84.2 - $98.62 $479,940 - $562,134
5,700 Added 0.04%
14,190,873 $1.26 Billion
Q4 2018

Feb 12, 2019
SELL
$80.14 - $106.07 $1.87 Million - $2.47 Million
-23,312 Reduced 0.16%
14,185,173 $1.21 Billion
Q3 2018

Nov 13, 2018
SELL
$93.92 - $105.72 $3.03 Million - $3.42 Million
-32,304 Reduced 0.23%
14,208,485 $1.38 Billion
Q2 2018

Aug 13, 2018
BUY
$76.01 - $99.03 $36 Million - $47 Million
474,250 Added 3.44%
14,240,789 $1.34 Billion
Q1 2018

May 14, 2018
BUY
$77.67 - $92.63 $273 Million - $326 Million
3,521,244 Added 34.37%
13,766,539 $1.12 Billion
Q4 2017

Feb 13, 2018
BUY
$80.76 - $95.13 $49 Million - $57.7 Million
606,651 Added 6.29%
10,245,295 $914 Million
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $777 Million - $915 Million
9,638,644
9,638,644 $897 Million

Others Institutions Holding BMRN

# of Institutions
672
Shares Held
185M
Call Options Held
1.28M
Put Options Held
1.1M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.6B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email